
1. Malar J. 2019 Aug 23;18(1):285. doi: 10.1186/s12936-019-2916-6.

Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to 
artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor
resistance surveillance in Africa?

Foguim Tsombeng F(1)(2)(3), Gendrot M(1)(2)(3), Robert MG(1)(2)(3), Madamet
M(1)(2)(3)(4), Pradines B(5)(6)(7)(8).

Author information: 
(1)Unité Parasitologie et Entomologie, Département Microbiologie et maladies
infectieuses, Institut de Recherche Biomédicale des Armées, 19-21 Boulevard Jean 
Moulin, 13005, Marseille, France.
(2)Aix Marseille Univ, IRD, SSA, AP-HM, VITROME, Marseille, France.
(3)IHU Méditerranée Infection, Marseille, France.
(4)Centre National de Référence du Paludisme, Institut de Recherche Biomédicale
des Armées, Marseille, France.
(5)Unité Parasitologie et Entomologie, Département Microbiologie et maladies
infectieuses, Institut de Recherche Biomédicale des Armées, 19-21 Boulevard Jean 
Moulin, 13005, Marseille, France. bruno.pradines@gmail.com.
(6)Aix Marseille Univ, IRD, SSA, AP-HM, VITROME, Marseille, France.
bruno.pradines@gmail.com.
(7)IHU Méditerranée Infection, Marseille, France. bruno.pradines@gmail.com.
(8)Centre National de Référence du Paludisme, Institut de Recherche Biomédicale
des Armées, Marseille, France. bruno.pradines@gmail.com.

Mutations in the propeller domain of Plasmodium falciparum kelch 13 (Pfk13) gene 
are associated with artemisinin resistance in Southeast Asia. Artemisinin
resistance is defined by increased ring survival rate and delayed parasite
clearance half-life in patients. Additionally, an amplification of the Plasmodium
falciparum plasmepsin II gene (pfpm2), encoding a protease involved in hemoglobin
degradation, has been found to be associated with reduced in vitro susceptibility
to piperaquine in Cambodian P. falciparum parasites and with
dihydroartemisinin-piperaquine failures in Cambodia. The World Health
Organization (WHO) has recommended the use of these two genes to track the
emergence and the spread of the resistance to dihydroartemisinin-piperaquine in
malaria endemic areas. Although the resistance to dihydroartemisinin-piperaquine 
has not yet emerged in Africa, few reports on clinical failures suggest that k13 
and pfpm2 would not be the only genes involved in artemisinin and piperaquine
resistance. It is imperative to identify molecular markers or drug resistance
genes that associate with artemisinin and piperaquine in Africa. K13
polymorphisms and Pfpm2 copy number variation analysis may not be sufficient for 
monitoring the emergence of dihydroartemisinin-piperaquine resistance in Africa. 
But, these markers should not be ruled out for tracking the emergence of
resistance.

DOI: 10.1186/s12936-019-2916-6 
PMCID: PMC6708145
PMID: 31443646  [Indexed for MEDLINE]

